<DOC>
	<DOCNO>NCT01043523</DOCNO>
	<brief_summary>Medical record review obtain information use MRI diagnostic imaging agent ( contrast agent ) call Primovist/Eovist child older 2 month le 18 year . Data record child 's medical record relate injection Primovist/Eovist collect . Information collect 2 week child receive Primovist/Eovist 12 month child receive Primovist/Eovist . Copy child 's MR image take right child receive Primovist/Eovist report ( laboratory report , image report , etc ) part child 's medical record time period collect .</brief_summary>
	<brief_title>Liver MRI With Primovist/Eovist Pediatric Subjects Who Are Suspected Have Focal Liver Lesions .</brief_title>
	<detailed_description />
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Abscess</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Abscess</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Age &gt; 2 month &lt; 18 year age time Primovist/Eovist enhance MRI MRI Primovist/Eovist due suspect known focal liver lesion Evaluable safety data Evaluable efficacy data : precontrast postcontrast magnetic resonance ( MR ) image must available review If criterion meet , principal investigator ( PI ) and/or designee obtain signed consent medical record release include access anonymized electronic copy pre postPrimovist/Eovist MRI scan , accordance local regulatory requirement order subject enrol study . A subject exclude observational / retrospective study subject previously enrol study . Subjects may enter study , even image multiple time different indication .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Liver neoplasm</keyword>
	<keyword>Adenoma</keyword>
	<keyword>Liver cell carcinoma</keyword>
	<keyword>Hepatocellular</keyword>
	<keyword>Liver abscess</keyword>
</DOC>